Why the study?
PJRT can cause incessant tachycardia in infants and children and is usually refractory to medical treatment.
Case Report (n=1)
Medical therapy with digoxin, amiodarone, and esmolol can be utilized to manage permanent junctional reciprocating tachycardia in a preterm neonate, potentially avoiding the need for catheter ablation.
May support medical management of PJRT in preterm neonates; hypothesis-generating and leaves open need for larger studies.
Permanent junctional reciprocating tachycardia (PJRT) is most often observed in infants and children and can lead to incessant tachycardia. PJRT is usually refractory to medical treatment. Tachycardia may infrequently occur in the fetus in which case fetal tachycardia transplacental treatment should be started immediately. Term delivery is recommended for fetuses with tachycardia in the absence of significant clinical compromise to avoid complications of preterm birth. Herein, a 36-week preterm neonate presented with PJRT. He had tachycardia in the fetal period and was treated with digoxin, amiodaron, and esmolol therapy after birth without undergoing the catheter ablation procedure.
No takes yet. Share an insight, caveat, or question.
İlhan et al. (2020) conducted a case report in Permanent junctional reciprocating tachycardia (PJRT) (n=1). Digoxin, amiodarone, and esmolol therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: